WorldCat Identities

Abraham, John 1961-

Works: 12 works in 64 publications in 2 languages and 1,022 library holdings
Genres: Case studies 
Roles: Author, Editor
Classifications: RM301.27, 344.04233
Publication Timeline
Most widely held works by John Abraham
Science, politics, and the pharmaceutical industry : controversy and bias in drug regulation by John Abraham( Book )

16 editions published between 1995 and 2003 in English and held by 222 WorldCat member libraries worldwide

Regulation of the pharmaceutical industry( Book )

8 editions published in 2003 in English and held by 157 WorldCat member libraries worldwide

This unique collection brings together the work of social scientists, ethicists, lawyers and policy analysts on regulation, ethics and innovation in the pharmaceutical industry. Regulatory systems and their implications for public health in North America, Europe and developing countries are discussed, including case studies of norplant, interferon and anti-fertility vaccines. The contributors analyse several key dimensions of the debate: national political culture; the Europeanization of regulatory decision-making; the globalization of scientific standard-setting and intellectual property rights in drug development; the impact of industrial innovation strategies on regulatory practices' secrecy and public accountability of regulatory agencies; the regulatory influence of users on medical technology; the ethics of drug development and research and the oligopolization of the industry. This book will be of great interest to all those concerned about how pharmaceuticals and medical technologies should be developed and controlled
Regulating medicines in Europe : competition, expertise, and public health by John Abraham( Book )

9 editions published between 2000 and 2014 in English and Portuguese and held by 144 WorldCat member libraries worldwide

"Regulating Medicines in Europe explains and investigates how medicines are controlled in Europe, especially the EU. Basing their book on penetrating documentary and interview research with the pharmaceutical industry, regulators and consumer organisations, John Abraham and Graham Lewis provide the first major critical examination of the new Europeanised systems of medicines regulation." "Regulating Medicines in Europe will prove a valuable resource to all those concerned with medicine regulation."--Jacket
The therapeutic nightmare : the battle over the world's most controversial sleeping pill by John Abraham( Book )

11 editions published between 1999 and 2014 in English and held by 103 WorldCat member libraries worldwide

How do drugs get to the market? What controls are there and what procedures for monitoring their effects? And how adequate are the regulators in protecting public health when new drugs have serious side effects? The Therapeutic Nightmare tells the story of the sleeping pill Halcion - a story which is far from over. First marketed in the 1970s, Halcion has been taken by millions of patients around the world. For many years it has been associated with serious adverse effects such as amnesia, hallucinations, aggression and, in extreme cases, homicide. Thirteen years after its first relea
Food and development : the political economy of hunger and the modern diet by John Abraham( Book )

5 editions published in 1991 in English and held by 97 WorldCat member libraries worldwide

Unhealthy pharmaceutical regulation : innovation, politics and promissory science by John Abraham( Book )

7 editions published in 2013 in English and held by 74 WorldCat member libraries worldwide

"European and American drug regulators govern a multi-billion-dollar pharmaceutical industry selling its products on the world's two largest medicines markets. This is the first book to investigate how effectively American and supranational EU governments have regulated innovative pharmaceuticals regarding public health during the neo-liberal era of the last 30 years. Drawing on years of fieldwork, the authors demonstrate that pharmaceutical regulation and innovation have been misdirected by commercial interests and misconceived ideologies, which induced a deregulatory political culture contrary to health interests. They dismantle the myth that pharmaceutical innovations necessarily equate with therapeutic advances and explain how it has been perpetuated in the interests of industry by corporate bias within the regulatory state, unwarranted expectations of promissory science, and the emergent patient-industry complex. Endemic across both continents, the misadventures of pharmaceutical deregulation are shown to span many therapeutic areas, including cancer, diabetes and irritable bowel syndrome. The authors propose political changes needed to redirect pharmaceutical regulation in the interests of health."--
Controlling pharmaceutical risks : science, cancer, and the geneticization of drug testing by John Abraham( Book )

1 edition published in 2014 in English and held by 4 WorldCat member libraries worldwide

The creation of neo-liberal corporate bias in transnational medecines control : the industrial shaping and interest dynamics of the European regulatory state( )

1 edition published in 2001 in English and held by 3 WorldCat member libraries worldwide

"Drawing on the political theories of corporatism, neo-liberalism and pluralism, and on comparative empirical research in Brussels, Germany, Sweden and the UK, this article conceptualises the nature of Europeanised medicines regulation. It argues that a marketisation of regulation has been established in the European Union as a result of competition between national regulatory agencies for "regulatory business" from the pharmaceutical industry. In the pharmaceuticals sector the Europeanised regulatory state is a product of three key factors: a) the European Commission's commitment to an "efficiency" regime which would meet the political objectives of a single European market and the commercial agendas of transnational pharmaceutical companies, b) the endemic corporate bias associated with medicines regulation in the most influential member states, and c) the considerable success of neo-liberal politics across a number of major member states, including Germany, Sweden and the United Kingdom."--Editor
Canadian forms & precedents by John Abraham( )

in English and held by 3 WorldCat member libraries worldwide

Multidimensional computations of premixed charge engine combustion by John Abraham( Book )

2 editions published between 1986 and 1987 in English and held by 2 WorldCat member libraries worldwide

The therapeutic nightmare : corporate power and drug safety : the battle over the world's most controversial tranquilliser by John Abraham( Book )

1 edition published in 1998 in English and held by 1 WorldCat member library worldwide

Science, politics and the pharmaceutical industry : controversy and regulation in drug development by John Abraham( Book )

1 edition published in 1995 in English and held by 0 WorldCat member libraries worldwide

moreShow More Titles
fewerShow Fewer Titles
Audience Level
Audience Level
  Kids General Special  
Audience level: 0.65 (from 0.58 for The therap ... to 1.00 for Science, p ...)

Regulation of the pharmaceutical industry
Regulation of the pharmaceutical industryRegulating medicines in Europe : competition, expertise, and public healthThe therapeutic nightmare : the battle over the world's most controversial sleeping pill